EMILY EGERTON-WARBURTON

Emily Egerton-Warburton is a biotechnology startup founder participating in the Y Combinator S24 batch and a biochemistry researcher based in Oxford, United Kingdom. She is currently completing her Part II Biochemistry studies at St Peter’s College within the University of Oxford, where she joined the Higgins Lab in 2024 to conduct advanced research on structure-guided vaccine design. Her previous domain expertise includes an eight-week research project at CyanoCapture focusing on cyanobacterial bioalkanes for biofuel production, alongside a summer internship at Inventprise working on a 25-valent pneumococcal vaccine. Most recently, she has applied generative diffusion models to de novo enzyme design, aiming to develop novel biological processes for a more sustainable chemical industry. Egerton-Warburton's background combines rigorous academic research with intensive biotech startup experience, focusing on the intersection of synthetic biology, artificial intelligence, and sustainable chemistry.